Private Sector Advisory Group members participated in the Annual PSD Retreat and Pre-Board meeting on September 10-11 in Lyon, France, to discuss the key Global Fund Board decisions. The Advisory Group also discussed broader issues facing the Fund, including organizational/governance reform, the search for a new executive director, options for the new funding model, a forecast of Global Fund assets and the future of the Affordable Medicines Facility- malaria. (AMFm is an innovative financing mechanism focused on increasing access to high quality anti-malarials.) The group discussed priorities for the PSD such as strengthening the partnership with the Global Fund Secretariat, private sector resource mobilization and the evolving role of the Focal Point. The retreat was graciously hosted by PSD Advisory Group member, Bayer.
An official delegation of Advisory Group members, led by Dr. Brian Brink (Private Sector Board member; Chief Medical Officer, Anglo American plc), went on to represent the private sector at the 27th Board meeting, from September 13-14 in Geneva, Switzerland. Major decisions from the Board meeting included:
Read more about the retreat and the Global Fund’s September Board Meeting here.